Clinical Trials Logo

Clinical Trial Summary

The objective of this feasibility study is to characterize the performance of the Aquadex FlexFlow® System with the hematocrit (HCT) feature in conjunction with Daxor's blood volume analyzer (BVA-100). The study will monitor blood volume changes during ultrafiltration (UF) therapy as a potential means to guide the removal of fluid in subjects hospitalized with acute decompensated heart failure (ADHF).


Clinical Trial Description

The study will measure blood volumes at various time intervals using the BVA-100 for comparison to corresponding readings of hematocrit (HCT) levels from the Aquadex FlexFlow HCT sensor. Establishing a correlation between BVA measurements (off-line measurements) and HCT sensor measurements (on-line measurements) may enable the use of the BVA-100 to guide ultrafiltration therapy by the Aquadex system for fluid removal. BVA-100 measurements would be used at baseline to accurately determine patient suitability for fluid removal and while HCT measurements would be used to monitor blood volume changes during ultrafiltration therapy, potentially guiding the removal of fluid in subjects hospitalized with ADHF. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04241718
Study type Interventional
Source Nuwellis, Inc.
Contact
Status Terminated
Phase N/A
Start date December 19, 2019
Completion date December 27, 2022

See also
  Status Clinical Trial Phase
Completed NCT04095143 - Ultrasound Markers of Organ Congestion in Severe Acute Kidney Injury
Terminated NCT03335124 - The Effect of Vitamin C, Thiamine and Hydrocortisone on Clinical Course and Outcome in Patients With Severe Sepsis and Septic Shock Phase 4
Completed NCT05070819 - Atrial Natriuretic Peptide in Assessing Fluid Status N/A
Withdrawn NCT04870073 - Retrograde Autologous Priming and Mannitol for Reducing Hemodilution in Cardiac Surgery Phase 3
Recruiting NCT02989051 - Fluid Restriction Keeps Children Dry Phase 2/Phase 3
Completed NCT00517127 - Crystalloids Versus Colloids During Surgery Phase 4
Completed NCT00852514 - The Optimization of Blood Pressure and Fluid Status Control With Eight-Polar Bioelectrical Impedance Analysis Phase 4
Not yet recruiting NCT05983549 - Neutral Versus Liberal fLuId In Traumatic Brain Injury: a Randomised Controlled Trial N/A
Completed NCT03929471 - Target Weight Correction and Vascular Stiffness in Hemodialysis Patients N/A
Recruiting NCT06071026 - Hemodynamic Effects of Variations in Net Ultrafiltration Rate During Continuous Renal Replacement Therapy. N/A
Completed NCT02903316 - Predicting Fluid Responsiveness in on Pump Coronary Artery Bypass Graft Using Extra Systoles N/A
Terminated NCT02458157 - Forced Fluid Removal in High Risk Acute Kidney Injury Phase 4
Completed NCT02325856 - Application of Bioimpedance Spectroscopy in Taiwan Dialysis Patients N/A
Completed NCT01628731 - Furosemide Versus Ethacrynic Acid in Children With Congenital Heart Disease Phase 3
Not yet recruiting NCT05647200 - Optimization of Prime Fluid Strategy to Preserve Microcirculatory Perfusion During Cardiac Surgery With Cardiopulmonary Bypass, Part II N/A
Completed NCT03768752 - Diastolic Dysfunction and Interstitial Lung Edema in Septic Patients
Terminated NCT03553394 - Effects of Restrictive Fluid Strategy on Postoperative Oliguric Pancreatic Surgery Patients N/A
Completed NCT06097923 - Implementation of Fluid Strategies Using Real-time Bioelectrical Analyzer in Surgical Intensive Care Unit (SICU) N/A
Recruiting NCT04215692 - Lung Ultrasound-guided Fluid Therapy in Pediatric Intensive Care Unit Patients N/A
Not yet recruiting NCT03322410 - Hydratation Status at Initiation of Peritoneal Dialysis: Study of the Role of Peritoneal Permeability N/A